Literature DB >> 847298

Interaction of o, p'DDT with the estrogen-binding protein (EBP) in human mammary and uterine tumors.

D Kupfer, W H Bulger.   

Abstract

The in vitro effect of o, p'DDT on the binding of 3H-estradiol-17beta (3H-E2) to the high affinity estrogen-binding protein(EBP) in cytosol derived from human mammary and uterine tumors was examined. o,p'DDT inhibited the binding of 3H-E2 to EBP in both breast and uterine tumors. Using Scatchard and Linweaver-Burk plot analyses, the inhibition by o,p'DDT of 3H-E2 binding to mammary tumors EBP appears to result from competition for the 8S moiety binding sites and not from deactivation of the binding sites. The KI for the inhibition by o,p.'DDT with EI binding was determined, yielding a value of 0.5 +/- 0.1 muM. The possible relevance of these findings to human population exposed to DDT derivatives is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 847298

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  4 in total

1.  p,p'-DDT is an estrogenic compound.

Authors:  S Bustos; J C Denegri; F Diaz; A N Tchernitchin
Journal:  Bull Environ Contam Toxicol       Date:  1988-10       Impact factor: 2.151

2.  Effect of p,p'-DDT and estrogen on the presence in the circulation and degranulation of blood eosinophil leukocytes.

Authors:  S Bustos; J Soto; N Bruzzone; V Vásquez; A N Tchernitchin
Journal:  Bull Environ Contam Toxicol       Date:  1995-08       Impact factor: 2.151

3.  Environmentally relevant xenoestrogen tissue concentrations correlated to biological responses in mice.

Authors:  E M Ulrich; A Caperell-Grant; S H Jung; R A Hites; R M Bigsby
Journal:  Environ Health Perspect       Date:  2000-10       Impact factor: 9.031

4.  Interaction of environmental chemicals with the estrogen and progesterone receptors from the oviduct of the American alligator.

Authors:  P M Vonier; D A Crain; J A McLachlan; L J Guillette; S F Arnold
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.